Pharma-Biotech Industry Helps Drive $14.4 Billion Industrial Project Activity in Massachusetts
Pharma-Biotech Industry Helps Drive $14.4 Billion Industrial Project Activity in Massachusetts
Attachment: Massachusetts Pharma, March 2014
SUGAR LAND--March 10, 2014--Researched by Industrial Info Resources (Sugar Land, Texas)--Pharmaceutical manufacturing and bioscience activity is growing in Massachusetts. Five years ago, Bristol-Myers Squibb Company (NYSE:BMY) (New Brunswick, New Jersey) located its first plant in Devens, Massachusetts, north of Boston, and the company has big plans for the campus in the future. Other biotech firms are following suit.
Other companies featured: Novo Nordisk A/V (NYSE:NVO), Johnson & Johnson (NYSE:JNJ)
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Contractor DPR Construction at Work on $8.8 Billion in U.S. Projects
- Turner Construction at Work on Projects Valued at $9.8 Billion
- ISPE Names the 2017 Pharmaceutical Facility of the Year Category Awards
- New England Invests $1.4 Billion in Fourth-Quarter 2016 Life Science Constr...
- Bristol-Myers Squibb's Devens Investment Tops $1 Billion for Biological Man...
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
